Overview
Drug Delivery and Translational Research, published by Springer Science+Business Media (United States), published 1,148 papers in 2021–2025, and its papers received 22,866 citations in those years. Its h-index is 92 and its two-year mean citedness is 7.08. On the ITS Journal Score it ranks #1,457 of 62,158 ranked journals and #8 of 168 in Pharmacology, Toxicology and Pharmaceutics.
Key figures
Citations count every citation the journal's papers received in these years, including citations to older papers. Two-year mean citedness is OpenAlex's measure of how often recent papers are cited; it is similar in idea to, but not the same as, an impact factor.
Papers and citations by year
| Year | Papers | Citations received | Open-access papers |
|---|---|---|---|
| 2020 | 177 | 7,329 | 59 |
| 2021 | 223 | 9,017 | 98 |
| 2022 | 183 | 5,227 | 88 |
| 2023 | 215 | 3,715 | 97 |
| 2024 | 267 | 3,622 | 138 |
| 2025 | 260 | 1,285 | 128 |
What it publishes
The leading research topics of its papers (OpenAlex topic classification). Select a topic to find other journals that publish on it.
Similar journals
Ranked journals that publish on the same topics.
| Journal | Field | Score | Papers 2021–2025 | Open access |
|---|---|---|---|---|
| Journal of Drug Delivery Science and Technology | Pharmacology, Toxicology and Pharmaceutics | 81.8 | 5,122 | 19% |
| Current Drug Delivery | Pharmacology, Toxicology and Pharmaceutics | 73.3 | 596 | 6% |
| Drug Delivery | Pharmacology, Toxicology and Pharmaceutics | 81.6 | 768 | 100% |
| European Journal of Pharmaceutics and Biopharmaceutics | Pharmacology, Toxicology and Pharmaceutics | 84.4 | 1,335 | 46% |
| Expert Opinion on Drug Delivery | Pharmacology, Toxicology and Pharmaceutics | 83.0 | 592 | 35% |
| Drug Delivery Letters | Pharmacology, Toxicology and Pharmaceutics | 48.3 | 162 | 6% |
| International Journal of Pharmaceutics | Pharmacology, Toxicology and Pharmaceutics | 88.7 | 5,635 | 35% |
| Pharmaceutics | Pharmacology, Toxicology and Pharmaceutics | 88.6 | 11,136 | 100% |
Compare with similar journals (side by side with the two closest journals above)
Identity and sources
- ISSN-L: 2190-393X
- Print ISSN: 2190-393X
- Electronic ISSN: 2190-3948
- Publisher: Springer Science+Business Media
- Listed in DOAJ: Not yet checked
- Crossref: ISSN found in Crossref
- OpenAlex: S2764352022
- Journal website: link.springer.com
Figures come from OpenAlex (papers, citations, h-index, topics), Crossref (ISSN check) and DOAJ (open-access listing and fees). They change as records are corrected, so treat them as a dated snapshot. This page does not state whether the journal is indexed in Scopus, Web of Science or PubMed.
Questions
What is the ITS Journal Score of Drug Delivery and Translational Research?
It is 82.2 out of 100, which places it #1,457 among ranked journals. The score combines citation impact (45%), h-index (35%) and size (20%) from open OpenAlex data.
What is the impact factor of Drug Delivery and Translational Research?
This site does not publish Journal Impact Factors, which belong to Clarivate. As an open alternative, its two-year mean citedness in OpenAlex is 7.08.
Is Drug Delivery and Translational Research open access?
48% of its papers from 2021–2025 are recorded as open access.
Does Drug Delivery and Translational Research charge a publication fee?
No fee is recorded in the open data used here. Check the journal's own website for its current fees.